{
  "resourceType": "StructureDefinition",
  "id": "ectd-composition-32s3",
  "url": "http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/ectd-composition-32s3",
  "name": "EctdComposition32S3",
  "title": "eCTD Substance Characterisation",
  "status": "active",
  "description": "The fields needed to represent the Substance Structure and Impurities to be included under the 3.2.S.3 heading of the eCTD. References Sponsor Organization, Drug Substance Structure, and Drug Substance Impurities",
  "fhirVersion": "5.0.0",
  "kind": "resource",
  "abstract": false,
  "type": "Composition",
  "baseDefinition": "http://hl7.org/fhir/StructureDefinition/Composition",
  "derivation": "constraint",
  "differential": {
    "element": [
      {
        "id": "Composition.identifier",
        "path": "Composition.identifier",
        "max": "1",
        "mustSupport": true
      },
      {
        "id": "Composition.status",
        "path": "Composition.status",
        "patternCode": "final"
      },
      {
        "id": "Composition.type",
        "path": "Composition.type",
        "patternCodeableConcept": {
          "coding": [
            {
              "code": "ich_3.2.s.3",
              "system": "http://terminology.hl7.org/temporary-uri/codeSystem/ICH-context-of-use",
              "display": "Characterisation"
            }
          ]
        }
      },
      {
        "id": "Composition.author",
        "path": "Composition.author",
        "max": "1",
        "type": [
          {
            "code": "Reference",
            "profile": [
              "http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/literal-reference"
            ],
            "targetProfile": [
              "http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/cmc-organization"
            ],
            "aggregation": [
              "bundled"
            ]
          }
        ],
        "mustSupport": true
      },
      {
        "id": "Composition.title",
        "path": "Composition.title",
        "mustSupport": true
      },
      {
        "id": "Composition.section",
        "path": "Composition.section",
        "slicing": {
          "discriminator": [
            {
              "type": "value",
              "path": "code"
            }
          ],
          "rules": "open",
          "description": "Slice based on the different sections that are needed in an ectd document."
        },
        "min": 1,
        "mustSupport": true
      },
      {
        "id": "Composition.section:Structure",
        "path": "Composition.section",
        "sliceName": "Structure",
        "definition": "Substance Characterisation to be included under the 3.2.S.3 eCTD heading.",
        "min": 1,
        "max": "1",
        "mustSupport": true
      },
      {
        "id": "Composition.section:Structure.title",
        "path": "Composition.section.title",
        "min": 1,
        "mustSupport": true
      },
      {
        "id": "Composition.section:Structure.code",
        "path": "Composition.section.code",
        "min": 1,
        "patternCodeableConcept": {
          "coding": [
            {
              "code": "ich_3.2.s.3.1",
              "system": "http://terminology.hl7.org/temporary-uri/codeSystem/ICH-context-of-use",
              "display": "Elucidation of Structure and other Characteristics"
            }
          ]
        },
        "mustSupport": true
      },
      {
        "id": "Composition.section:Structure.entry",
        "path": "Composition.section.entry",
        "min": 1,
        "max": "1",
        "type": [
          {
            "code": "Reference",
            "profile": [
              "http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/literal-reference"
            ],
            "targetProfile": [
              "http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-drug-substance-characterisation"
            ],
            "aggregation": [
              "bundled"
            ]
          }
        ],
        "mustSupport": true
      }
    ]
  }
}
